Monoclonal antibody (mAb) has made dramatic progress in the diagnosis and treatment of human diseases since its advent in the 1980s, and have developed as one of the most usefully and valuable therapeutic molecules in clinic. mAbs directly target the glycan determinants (namely anti-glycan mAbs) currently have been widely applied for the research of the expression, identification, distribution, and function of glycan antigens in cells and tissues. For a distance, mAbs against tumor-associated carbohydrate antigens are promisingly used for several cancers diagnosis and treatment, and mAbs to some glycolipid or glycoconjugates can be utilized for the analysis of carbohydrate-mediated cell adhesion. These anti-glycan mAbs have significantly improved the current research status and microanalysis of glycoconjugates.
Creative Biolabs has developed an advanced platform that enables us to offer various anti-carbohydrate monoclonal antibodies for global customers using our phage display or hybridoma technology. Based on our top technology, our anti-carbohydrate antibodies could recognize both glycolipids and glycoproteins.
Furthermore, these antibodies can be used for multiple applications, such as immunohistochemistry, cell-staining, inhibition assay for cell adhesion, flow cytometry, ELISA and other biological experiments.
As a senior antibody provider, Creative Biolabs produces and offers a diversity of pre-made or customized anti-glycan monoclonal antibodies using our well-constructed antibody platforms. Please feel free to contact us and communicate with us about your specific needs, our scientists will reply to you as soon as possible.
Browse Monoclonal Antibody based on alphabetical listing:
0-9
A
B
C
D
E
F
G
H
K
L
M
N
O
P
R
S
T
V
X
Other